Mingli Han

2.0k total citations
24 papers, 840 citations indexed

About

Mingli Han is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Mingli Han has authored 24 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cancer Research, 15 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Mingli Han's work include MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (11 papers) and Circular RNAs in diseases (7 papers). Mingli Han is often cited by papers focused on MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (11 papers) and Circular RNAs in diseases (7 papers). Mingli Han collaborates with scholars based in China and Macao. Mingli Han's co-authors include Yimeng Wang, Manran Liu, Dongwei Dou, Yuanting Gu, Xin Ge, Liuyang Zhao, Chun‐Ying Wu, Xin Chen, Yuanming Fan and Yan Sun and has published in prestigious journals such as PLoS ONE, Archives of Biochemistry and Biophysics and Nutrients.

In The Last Decade

Mingli Han

22 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingli Han China 14 683 601 161 52 37 24 840
Dianwen Han China 15 890 1.3× 727 1.2× 94 0.6× 84 1.6× 79 2.1× 26 1.0k
Elena Jelezcova United States 7 593 0.9× 422 0.7× 99 0.6× 37 0.7× 30 0.8× 7 689
Deyao Wu China 14 615 0.9× 587 1.0× 70 0.4× 65 1.3× 48 1.3× 19 748
Enhua Wang China 16 651 1.0× 614 1.0× 154 1.0× 73 1.4× 92 2.5× 26 867
Roberto Cirombella Italy 9 459 0.7× 455 0.8× 72 0.4× 50 1.0× 48 1.3× 17 640
Lu Xu China 15 463 0.7× 363 0.6× 97 0.6× 69 1.3× 47 1.3× 37 592
Jianhua Xu China 17 553 0.8× 518 0.9× 91 0.6× 34 0.7× 36 1.0× 29 716
Jue‐Yu Zhou China 15 426 0.6× 278 0.5× 110 0.7× 54 1.0× 42 1.1× 42 591
Arianna Giacobbe Italy 7 385 0.6× 252 0.4× 188 1.2× 43 0.8× 28 0.8× 7 520

Countries citing papers authored by Mingli Han

Since Specialization
Citations

This map shows the geographic impact of Mingli Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingli Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingli Han more than expected).

Fields of papers citing papers by Mingli Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingli Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingli Han. The network helps show where Mingli Han may publish in the future.

Co-authorship network of co-authors of Mingli Han

This figure shows the co-authorship network connecting the top 25 collaborators of Mingli Han. A scholar is included among the top collaborators of Mingli Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingli Han. Mingli Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xu, Yanmei, Fengliang Wang, Wenjing Peng, et al.. (2025). Exploring the potential molecular targets and therapeutic mechanisms of Cyperi Rhizoma in treating diabetic cardiomyopathy: a computational approach. RSC Advances. 15(29). 23920–23933. 1 indexed citations
3.
Dong, Huaying, et al.. (2024). LncRNA ZNF649-AS1 promotes trastuzumab resistance and TAM-dependent PD-L1 expression in breast cancer by regulating EXOC7 alternative splicing. Archives of Biochemistry and Biophysics. 761. 110128–110128. 2 indexed citations
4.
Xiao, Na, et al.. (2023). Chlorogenic Acid Inhibits Ceramide Accumulation to Restrain Hepatic Glucagon Response. Nutrients. 15(14). 3173–3173. 3 indexed citations
5.
Wang, Fang, et al.. (2023). Metabolic characteristics of the various incision margins for breast cancer conservation surgery. Frontiers in Oncology. 12. 959454–959454.
6.
7.
Wang, Fang, Xiaochun Wang, Jingruo Li, et al.. (2021). CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling. Journal of Biomedical Science. 28(1). 4–4. 34 indexed citations
8.
Wang, Fang, Xiaochun Wang, Jingruo Li, et al.. (2021). Correction to: CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling. Journal of Biomedical Science. 28(1). 31–31. 4 indexed citations
9.
Dou, Dongwei, Xiaoyang Ren, Mingli Han, et al.. (2020). CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis. Cancer Cell International. 20(1). 454–454. 79 indexed citations
10.
Han, Mingli, Xueke Qian, Hui Cao, et al.. (2020). lncRNA ZNF649-AS1 Induces Trastuzumab Resistance by Promoting ATG5 Expression and Autophagy. Molecular Therapy. 28(11). 2488–2502. 44 indexed citations
11.
Dou, Dongwei, Xiaoyang Ren, Mingli Han, et al.. (2020). Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR‐140‐3p/SKA2 axis. Molecular Oncology. 15(2). 697–709. 53 indexed citations
13.
Dou, Dongwei, Xin Ge, Xinxing Wang, et al.. (2019). <p>EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression</p>. OncoTargets and Therapy. Volume 12. 9627–9637. 29 indexed citations
14.
Han, Mingli, Yimeng Wang, Li Lin, et al.. (2018). microRNA‐30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway. Journal of Cellular Biochemistry. 119(10). 8138–8145. 35 indexed citations
15.
Guo, Guangcheng, et al.. (2017). microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. Cellular Oncology. 40(2). 157–166. 40 indexed citations
16.
Han, Mingli, Fang Wang, Yuanting Gu, et al.. (2016). MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG. Biomedicine & Pharmacotherapy. 80. 304–310. 39 indexed citations
17.
Lv, Pengwei, et al.. (2015). Angiotensin II type 1 receptor gene A1166C polymorphism and breast cancer susceptibility. Genetics and Molecular Research. 14(4). 15016–15023. 3 indexed citations
18.
Han, Mingli, Fang Wang, Yuanting Gu, et al.. (2015). MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-β pathways. Oncology Reports. 35(1). 73–80. 44 indexed citations
19.
20.
Han, Mingli, Manran Liu, Yimeng Wang, et al.. (2012). Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTEN. PLoS ONE. 7(6). e39520–e39520. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026